These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30056883)

  • 1. Results of Renal Transplant From Deceased Anti-hepatitis C Virus Donors, Poland 1998-2012.
    Pliszczyński J; Jasztal K; Jóźwik A; Kosieradzki M; Danielewicz R; Małkowski P; Czerwiński J
    Transplant Proc; 2018; 50(6):1691-1696. PubMed ID: 30056883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing increased risk for disease transmission (IRD) kidneys for pediatric renal transplant recipients.
    Hwang CS; Gattineni J; MacConmara M
    Pediatr Nephrol; 2019 Oct; 34(10):1743-1751. PubMed ID: 31243535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Outcomes of Multivisceral Transplant Using Hepatitis C-Positive Donors.
    McMaster WG; Rahaman ZM; Shipe ME; Quintana EN; Sandhaus EM; Smith SS; Crockett JE; Forbes RC; Schlendorf KH; Shah AS
    Ann Thorac Surg; 2021 Aug; 112(2):511-518. PubMed ID: 33121968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients.
    Sageshima J; Troppmann C; McVicar JP; Santhanakrishnan C; de Mattos AM; Perez RV
    Transplantation; 2018 Jul; 102(7):1179-1187. PubMed ID: 29953423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus).
    Natov SN
    Transpl Infect Dis; 2002 Sep; 4(3):124-31. PubMed ID: 12421456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.
    Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients.
    Kim SM; Kim HW; Lee EK; Park SK; Han DJ; Kim SB
    Transplantation; 2013 Jul; 96(1):85-90. PubMed ID: 23632392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of kidneys from HCV-positive donors: a safe strategy?
    Fabrizi F; Bunnapradist S; Lunghi G; Martin P
    J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
    Minz M; Sharma A; Das A; Chawla Y
    Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
    Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
    Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
    Pereira BJ; Wright TL; Schmid CH; Levey AS
    Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
    Singh N; Neidlinger N; Djamali A; Leverson G; Voss B; Sollinger HW; Pirsch JD
    Clin Transplant; 2012; 26(5):684-93. PubMed ID: 22283142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV.
    Morales JM; Campistol JM; Castellano G; Andres A; Colina F; Fuertes A; Ercilla G; Bruguera M; Andreu J; Carretero P
    Kidney Int; 1995 Jan; 47(1):236-40. PubMed ID: 7537343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic responses to hepatitis C virus in solid organ transplant recipients.
    Preiksaitis JK; Cockfield SM; Fenton JM; Burton NI; Chui LW
    Transplantation; 1997 Dec; 64(12):1775-80. PubMed ID: 9422419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.